- Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depressionA J Claxton
Eli Lilly and Company, Indianapolis, IN 46285, USA
Br J Psychiatry 177:163-8. 2000..Patients with depression are often not prescribed antidepressants for an adequate period of time...
- Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorderA Claxton
Lilly Research Laboratories, Indianapolis, Ind 46285, USA
J Clin Psychiatry 61:928-32. 2000..A new formulation of enteric-coated fluoxetine given once weekly could be a useful option for the long-term treatment of depression, but compliance to once-weekly fluoxetine treatment has not been assessed...
- A systematic review of the associations between dose regimens and medication complianceA J Claxton
Global Health Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
Clin Ther 23:1296-310. 2001..However, compliance in most of these studies was based on patient self-report, blood-level monitoring, prescription refills, or pill count data, none of which are as accurate as electronic monitoring (EM)...